Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.12), $0.11 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.